Acide pamidronique [INN-French]
Acide pamidronique [INN-French] Brand names, Acide pamidronique [INN-French] Analogs
Acide pamidronique [INN-French] Brand Names Mixture
- No information avaliable
Acide pamidronique [INN-French] Chemical_Formula
C3H11NO7P2
Acide pamidronique [INN-French] RX_link
http://www.rxlist.com/cgi/generic/aredia.htm
Acide pamidronique [INN-French] fda sheet
Acide pamidronique [INN-French] msds (material safety sheet)
Acide pamidronique [INN-French] Synthesis Reference
No information avaliable
Acide pamidronique [INN-French] Molecular Weight
235.07 g/mol
Acide pamidronique [INN-French] Melting Point
No information avaliable
Acide pamidronique [INN-French] H2O Solubility
No information avaliable
Acide pamidronique [INN-French] State
No information avaliable
Acide pamidronique [INN-French] LogP
-3.048
Acide pamidronique [INN-French] Dosage Forms
Liquid; Powder for solution; Solution
Acide pamidronique [INN-French] Indication
For the treatment of moderate or severe hypercalcemia associated with malignancy
Acide pamidronique [INN-French] Pharmacology
Pamidronate is in a class of drugs called bisphosphonates. Pamidronate reduces breakdown of the bones. Pamidronate is used in the treatment of Paget's disease of bone; to reduce high levels of calcium in the blood associated with malignancy (cancer); and to reduce the breakdown of bone due to metastases of breast cancer or multiple myeloma.
Acide pamidronique [INN-French] Absorption
No information avaliable
Acide pamidronique [INN-French] side effects and Toxicity
Side effects include an allergic reaction, kidney problems, seizures, low levels of calcium, magnesium, or phosphorus in the blood
Acide pamidronique [INN-French] Patient Information
No information avaliable
Acide pamidronique [INN-French] Organisms Affected
Humans and other mammals
![Acide_pamidronique_[INN-French]](/images/rx/APRD01161.gif)
